448 related articles for article (PubMed ID: 8452322)
21. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
[TBL] [Abstract][Full Text] [Related]
22. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.
Björck S; Mulec H; Johnsen SA; Nyberg G; Aurell M
BMJ; 1990 Apr; 300(6729):904-7. PubMed ID: 2337713
[TBL] [Abstract][Full Text] [Related]
23. Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients.
Ruggenenti P; Mosconi L; Bianchi L; Cortesi L; Campana M; Pagani G; Mecca G; Remuzzi G
Am J Kidney Dis; 1994 Nov; 24(5):753-61. PubMed ID: 7977316
[TBL] [Abstract][Full Text] [Related]
24. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
25. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
[TBL] [Abstract][Full Text] [Related]
26. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
27. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients.
Sano T; Kawamura T; Matsumae H; Sasaki H; Nakayama M; Hara T; Matsuo S; Hotta N; Sakamoto N
Diabetes Care; 1994 May; 17(5):420-4. PubMed ID: 8062609
[TBL] [Abstract][Full Text] [Related]
29. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Chapman AB; Brosnahan GM; Edelstein CL; Johnson AM; Schrier RW
Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
[TBL] [Abstract][Full Text] [Related]
30. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
[TBL] [Abstract][Full Text] [Related]
31. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
[TBL] [Abstract][Full Text] [Related]
32. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
33. Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus. A randomized clinical trial.
Zandbergen AA; Baggen MG; Lamberts SW; Bootsma AH; de Zeeuw D; Ouwendijk RJ
Ann Intern Med; 2003 Jul; 139(2):90-6. PubMed ID: 12859158
[TBL] [Abstract][Full Text] [Related]
34. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics.
Baba S;
Diabetes Res Clin Pract; 2001 Dec; 54(3):191-201. PubMed ID: 11689274
[TBL] [Abstract][Full Text] [Related]
35. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
[TBL] [Abstract][Full Text] [Related]
36. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
Viberti G; Mogensen CE; Groop LC; Pauls JF
JAMA; 1994 Jan; 271(4):275-9. PubMed ID: 8295285
[TBL] [Abstract][Full Text] [Related]
37. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Kolkhof P; Joseph A; Pieper A; Kimmeskamp-Kirschbaum N; Ruilope LM;
JAMA; 2015 Sep; 314(9):884-94. PubMed ID: 26325557
[TBL] [Abstract][Full Text] [Related]
38. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.
Marre M; Puig JG; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion Júnior D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Gallois Y; Amouyel P; Ollivier JP; Asmar R
J Hypertens; 2004 Aug; 22(8):1613-22. PubMed ID: 15257186
[TBL] [Abstract][Full Text] [Related]
39. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
Jacobsen P; Andersen S; Rossing K; Jensen BR; Parving HH
Kidney Int; 2003 May; 63(5):1874-80. PubMed ID: 12675866
[TBL] [Abstract][Full Text] [Related]
40. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
Epstein M; Williams GH; Weinberger M; Lewin A; Krause S; Mukherjee R; Patni R; Beckerman B
Clin J Am Soc Nephrol; 2006 Sep; 1(5):940-51. PubMed ID: 17699311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
